Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138162244> ?p ?o ?g. }
- W3138162244 endingPage "390" @default.
- W3138162244 startingPage "390" @default.
- W3138162244 abstract "Adjuvant CIA09, composed of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-based cationic liposomes and the toll-like receptor 4 agonist de-O-acylated lipooligosaccharide (dLOS), has been shown to enhance antibody and cellular immune responses to varicella-zoster virus (VZV) glycoprotein E (gE), recombinant tuberculosis vaccine antigen, and inactivated Japanese encephalitis vaccine. In this study, we investigated its modes of action using VZV gE as a model antigen. Liposomes adsorbed gE and cooperatively with dLOS promoted endocytosis-mediated cellular uptake of gE by mouse dendritic cells in vitro. CIA09 increased the stability and cellular uptake of the antigen at the muscle site of injection, and induced immune cell recruitment and cytokine and chemokine production, which led to efficient antigen delivery to draining lymph nodes. Mouse bone marrow-derived dendritic cells, pulsed with CIA09-adjuvanted gE, efficiently presented gE to antigen-specific T cells, inducing Th1-type biased immunity, as shown by high IFN-γ production. The data indicate that liposomes and dLOS cooperate in the adjuvant activity of CIA09 by promoting antigen uptake and delivery to lymph nodes as well as antigen presentation to T cells." @default.
- W3138162244 created "2021-03-29" @default.
- W3138162244 creator A5006702854 @default.
- W3138162244 creator A5012336510 @default.
- W3138162244 creator A5020014401 @default.
- W3138162244 creator A5040304972 @default.
- W3138162244 creator A5051177236 @default.
- W3138162244 creator A5056324202 @default.
- W3138162244 creator A5062517488 @default.
- W3138162244 creator A5069655482 @default.
- W3138162244 creator A5085326377 @default.
- W3138162244 creator A5090693449 @default.
- W3138162244 date "2021-03-15" @default.
- W3138162244 modified "2023-10-11" @default.
- W3138162244 title "The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes" @default.
- W3138162244 cites W1661544713 @default.
- W3138162244 cites W1964334838 @default.
- W3138162244 cites W1965235573 @default.
- W3138162244 cites W1968114019 @default.
- W3138162244 cites W1975499385 @default.
- W3138162244 cites W1976644560 @default.
- W3138162244 cites W1984658883 @default.
- W3138162244 cites W1986211799 @default.
- W3138162244 cites W1988981316 @default.
- W3138162244 cites W1989601820 @default.
- W3138162244 cites W1990635325 @default.
- W3138162244 cites W1999033561 @default.
- W3138162244 cites W2000892693 @default.
- W3138162244 cites W2004062771 @default.
- W3138162244 cites W2004687635 @default.
- W3138162244 cites W2006091616 @default.
- W3138162244 cites W2011549847 @default.
- W3138162244 cites W2017070606 @default.
- W3138162244 cites W2020483175 @default.
- W3138162244 cites W2029884055 @default.
- W3138162244 cites W2033322939 @default.
- W3138162244 cites W2034197799 @default.
- W3138162244 cites W2044672740 @default.
- W3138162244 cites W2048492655 @default.
- W3138162244 cites W2048756080 @default.
- W3138162244 cites W2048961513 @default.
- W3138162244 cites W2057692685 @default.
- W3138162244 cites W2083290601 @default.
- W3138162244 cites W2083407483 @default.
- W3138162244 cites W2098351459 @default.
- W3138162244 cites W2120404094 @default.
- W3138162244 cites W2134113130 @default.
- W3138162244 cites W2137613681 @default.
- W3138162244 cites W2152842365 @default.
- W3138162244 cites W2170240282 @default.
- W3138162244 cites W2296598106 @default.
- W3138162244 cites W2327361555 @default.
- W3138162244 cites W2482786872 @default.
- W3138162244 cites W2553247314 @default.
- W3138162244 cites W2724154348 @default.
- W3138162244 cites W2769803323 @default.
- W3138162244 cites W2794370011 @default.
- W3138162244 cites W2810902168 @default.
- W3138162244 cites W2887675884 @default.
- W3138162244 cites W2919062392 @default.
- W3138162244 cites W2942812484 @default.
- W3138162244 cites W2943197912 @default.
- W3138162244 cites W2950016548 @default.
- W3138162244 cites W3023152189 @default.
- W3138162244 cites W3037133185 @default.
- W3138162244 doi "https://doi.org/10.3390/pharmaceutics13030390" @default.
- W3138162244 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8001429" @default.
- W3138162244 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33804176" @default.
- W3138162244 hasPublicationYear "2021" @default.
- W3138162244 type Work @default.
- W3138162244 sameAs 3138162244 @default.
- W3138162244 citedByCount "7" @default.
- W3138162244 countsByYear W31381622442021 @default.
- W3138162244 countsByYear W31381622442022 @default.
- W3138162244 countsByYear W31381622442023 @default.
- W3138162244 crossrefType "journal-article" @default.
- W3138162244 hasAuthorship W3138162244A5006702854 @default.
- W3138162244 hasAuthorship W3138162244A5012336510 @default.
- W3138162244 hasAuthorship W3138162244A5020014401 @default.
- W3138162244 hasAuthorship W3138162244A5040304972 @default.
- W3138162244 hasAuthorship W3138162244A5051177236 @default.
- W3138162244 hasAuthorship W3138162244A5056324202 @default.
- W3138162244 hasAuthorship W3138162244A5062517488 @default.
- W3138162244 hasAuthorship W3138162244A5069655482 @default.
- W3138162244 hasAuthorship W3138162244A5085326377 @default.
- W3138162244 hasAuthorship W3138162244A5090693449 @default.
- W3138162244 hasBestOaLocation W31381622441 @default.
- W3138162244 hasConcept C147483822 @default.
- W3138162244 hasConcept C159047783 @default.
- W3138162244 hasConcept C185592680 @default.
- W3138162244 hasConcept C203014093 @default.
- W3138162244 hasConcept C2776090121 @default.
- W3138162244 hasConcept C2777863537 @default.
- W3138162244 hasConcept C2911179620 @default.
- W3138162244 hasConcept C83464605 @default.
- W3138162244 hasConcept C86803240 @default.
- W3138162244 hasConcept C8891405 @default.
- W3138162244 hasConceptScore W3138162244C147483822 @default.